Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exjade in Porphyria Cutanea Tarda
NCT01284946Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferasirox in porphyria cutanea tarda (PCT), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
deferasirox
03
Conditions
porphyria cutanea tarda (PCT)
Beyond the preview
Go deeper on NCT01284946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01284946.